DCSSC

Clinical trials for DCSSC explained in plain language.

Never miss a new study

Get alerted when new DCSSC trials appear

Sign up with your email to follow new studies for DCSSC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Cancer drug repurposed to fight rare scleroderma in early trial

Disease control Completed

This early-phase study tested a drug called brentuximab vedotin, originally used for lymphoma, in 17 people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The main goal was to see if the drug is safe and tolerable. Researchers monitored for serious side…

Matched conditions: DCSSC

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

DCSSC

Get alerted when new DCSSC trials appear

Cancer drug repurposed to fight rare scleroderma in early trial